The Drug Discovery market size is expected to reach $250.51 billion in 2030 at a CAGR of 15.1%, driven by rising healthcare expenditure.
Read More
The Doxorubicin market size is expected to reach $2 billion in 2030 at a CAGR of 7.2%, driven by increasing cancer prevalence.
Read More
The Dopamine Agonists market size is expected to reach $3.86 billion in 2030 at a CAGR of 7.1%, driven by rising neurological disorder prevalence.
Read More
The global Donepezil market size is expected to reach $1.3 billion in 2030 at a CAGR of 4.5%, driven by rising Alzheimer’s disease prevalence.
Read More
The Docosahexaenoic Acid (DHA) Supplements market size is expected to reach $3.43 billion in 2030 at a CAGR of 10.1%, driven by increasing dietary supplement adoption.
Read More
The global Docetaxel market size is expected to reach $2.36 billion in 2030 at a CAGR of 6.7%, driven by growing cancer prevalence.
Read More
The DNA Synthesis market size is expected to reach $13.06 billion in 2030 at a CAGR of 20.2%, driven by increasing demand for personalized medicine.
Read More
The DNA Repair Drugs market size is expected to reach $32.21 billion in 2030 at a CAGR of 20.0%, driven by rising cancer prevalence.
Read MoreThe Diuretics market size is expected to reach $0.92 billion in 2030 at a CAGR of 3.7%, driven by increasing kidney disorder cases.
Read More
The Disruptive Behavior Disorder Treatment market size is expected to reach $2.15 billion in 2030 at a CAGR of 5.8%, driven by rising mental illness prevalence.
Read More